Mariner Wealth Advisors (NYC)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$11K	Buy	+79	New	+$9.79K	0.01%	360

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s BIO Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2015: 79 shares worth $11K. The stake represents 0.01% of the portfolio and ranks #360 among its holdings.

219 funds tracked by Wall St. Rank hold BIO as of Q1 2015.

Mariner Wealth Advisors (NYC) held 79 shares of Bio-Rad Laboratories Class A worth $11K as of Q1 2015.
Bio-Rad Laboratories Class A was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Bio-Rad Laboratories Class A made up 0.01% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #360 holding.
219 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.